Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

kinase inhibitor UCT-01-097

An orally bioavailable kinase inhibitor, with potential antineoplastic activity. Upon oral administration, kinase inhibitor UCT-01-097 may target, bind to and inhibit the activity of one or more kinases that play a key role in tumor cell proliferation.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	UCT 01-097 UCT-01-097

kinase inhibitor UCT-01-097

Search NCI's Drug Dictionary